George W LeMaitre sold $22M of LMAT
Chairman and CEO at LEMAITRE VASCULAR INC. 205,930 shares at an average of $107.04, traded Feb 26, 2026, filed Mar 2, 2026.
Score components
- +25RoleCEO
- +25Trade size$22.0M at market
- +5Share of holdings soldSold 12% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.5%, 3m -14.5%, 6m -24.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-086259, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | SOpen-market sale Common Stock10b5-1 | -150,000 | $106.76 | $16M | 1,532,304 | Mar 2, 2026 |
| Feb 26, 2026 | AGrant or award Common Stock10b5-1 | +5,609 | $0.00 | $0 | 1,537,913 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Common Stock10b5-1 | +13 | $0.00 | $0 | 1,537,926 | Mar 2, 2026 |
| Feb 26, 2026 | FTax withholding Common Stock10b5-1 | -496 | $113.69 | $56k | 1,537,430 | Mar 2, 2026 |
| Mar 2, 2026 | GGift Common Stock10b5-1 | -5,000 | $0.00 | $0 | 1,532,430 | Mar 2, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock10b5-1 | -55,930 | $107.81 | $6.0M | 1,476,500 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Dividend Equivalent Rightsderivative10b5-1 | -13 | $0.00 | $0 | 33 | Mar 2, 2026 |
Related signals
Other insiders at LEMAITRE VASCULAR INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | LEMAITRE VASCULAR INC | Lawrence J Jasinski director | $434k 3,943 shares | -46% | |
| 54Moderate | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $313k 2,928 shares | -44% | |
| 54Moderate | LEMAITRE VASCULAR INC | Bridget A Ross director | $560k 5,044 shares | -56% | |
| 65Notable | LEMAITRE VASCULAR INC | George W LeMaitre Chairman and CEO | $5.0M 46,481 shares | -3% | |
| 39Weak | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $285k 2,625 shares | -28% | |
| 55Moderate | LEMAITRE VASCULAR INC | David B Roberts President and Director | $357k 3,312 shares | -18% | |
| 30Weak | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $115k 1,044 shares | -14% | |
| 54Moderate | LEMAITRE VASCULAR INC | David B Roberts President and Director | $904k 8,464 shares | -32% | |
| 44Moderate | LEMAITRE VASCULAR INC | Lawrence J Jasinski director | $91k 976 shares | -17% | |
| 56Moderate | LEMAITRE VASCULAR INC | John A Roush director | $695k 7,500 shares | -195% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.